Abstracts

Citation

Kulkanya Chokephaibulkit, M.D., Tim Roy Cressey, B.Sc., Ph.D., Wasana Prasitsuebsai, M.D., Nirun Vanprapar, M.D., M.Sc., Tawee Chotpitayasunondh, M.D., Koen Frederix, Ram Yogev, M.D., Edmund Capparelli, Pharm.D. Nevirapine exposure in Thai children receiving an adult or pediatric fixed-dose combination of stavudine (d4T), lamivudine (3TC) and nevirapine (NVP). Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Carlum Shiu, Coleen K. Cunningham, M.D., Carrie Ziemniak, Petronella Muresan, M.S., Lawrence Fox, M.D., Ph.D., Aditya Gaur, M.D., Irma L. Febo Rodriguez, M.D., Katherine Luzuriaga, M.D., Deborah Persaud, M.D. Safety and analyses of very low-level viremia during therapeutic HIV-1 immunizations in young adults on HAART: long-term persistence of dominant plasma clones derived from residual replication-competent virus in CD4+ T cells. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Aditya Gaur, M.D., Marvin Eric Belzer, M.D., Paula Britto, M.S., Patricia A. Garvie, Ph.D., ChengCheng Hu, Ph.D., Bobbie L. Graham, B.S., Karin L. Klingman, M.D., Michael N. Neely, M.D., George D. McSherry, M.D., Patricia M. Flynn, M.D., M.S. Directly observed therapy for non-adherent HIV infected adolescents - lessons learned, challenges ahead. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Akihiko Saitoh, M.D., Elizabeth Sarles, Edmund Capparelli, Pharm.D., Francesca Aweeka, Pharm.D., Andrea Kovacs, M.D., Sandra K. Burchett, M.D., M.S., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Terence Fenton, Ed.D., Stephen A. Spector, M.D. CYP2C19 genetic variants affect nelfinavir and M8 pharmacokinetics and virologic response in HIV-1 infected children receiving HAART. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

David W. Ouyang, M.D., Susan Brogly, Ph.D., Ming Lu, Ronald C. Hershow, M.D., David E. Shapiro, Ph.D., Audrey French, Rob Leighty, Ph.D., Bruce Thompson, Ruth E. Tuomala, M.D. Lack of increased hepatotoxicity in pregnant women receiving nevirapine compared to other ARV. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Marilyn Jean Crain, M.P.H., M.D., Miriam Chernoff, Ph.D., James M. Oleske, M.D., Susan Brogly, Ph.D., Kathleen Malee, Ph.D., Peggy R. Borum, Ph.D., Wendy G Mitchell, M.D., Heather Ford-Chatterton, B.S.N., Russell B. Van Dyke, M.D., George Seage, III, Sc.D., M.P.H. Possible mitochondrial dysfunction in a large U.S. cohort of HIV-infected children. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Benjamin Chi, M.D., Lisa M. Frenkel, M.D., Grace M. Aldrovandi, MD, Namwinga Chintu, MMED, R. Cantrell, Felistas Mbewe, R.N., G. M. Ellis, Elizabeth Stringer, M.D., K. Nakamura, Jeffrey S.A. Stringer, M.D. Intrapartum tenofovir and emtricitabine reduces development of low-level NNRTI resistance following ingestion of single-dose nevirapine (NVP) for perinatal HIV prevention. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Susan A. Fiscus, Ph.D., Ada Cachafeiro, Sonia Napravnik, M.P.H., Ph.D. The Cavidi Exavir viral load and phenotype assays in comparison to HIV-1 RNA and genotyping assays. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Caroline Mitchell, M.D. HIV-1 DNA yield from dried blood spots is diminished after storage at 37C compared to -20C. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Karin Alvarenga-Hyldgaard Nielsen, M.D., M.P.H., Heather D. Watts, M.D., Jose Henrique Pilotto, M.D., Esau Custodio Joao (Filho), M.D., Glenda E. Gray, James Alasdair McIntyre, M.D., James Bethel, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Margaret Camarca, M.P.H., John ( Jack ) Moye, Jr., M.D. Infectious morbidity and mortality in formula fed infants born to women infected by HIV. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.